Metastatic Patterns and Prognosis in Colorectal Cancer

Colorectal cancer (CRC) ranks among the most common malignancies worldwide and remains a leading cause of cancer‐related mortality. Metastatic dissemination is the principal driver of poor outcomes, with the liver, lung, peritoneum, bone and brain constituting the main secondary sites. Patterns of spread vary according to primary tumour location, histological subtype and molecular profile. Rectal tumours more often seed the thorax and central nervous system, whereas colon tumours favour the liver and peritoneum. Mucinous and signet‐ring histologies show a predisposition for peritoneal carriage and reduced hepatic colonisation. Prognosis is heavily influenced by the number and timing of metastases: synchronous lesions detected at diagnosis carry a worse outlook than metachronous deposits emerging after initial treatment. Survival varies from a few months in untreated advanced disease to over five years when solitary metastases are resected. Advances in surgical techniques, systemic therapy and locoregional ablation have extended median survival, yet individual risk stratification remains a challenge. An enhanced understanding of metastatic tropism and refined prognostic models promises to optimise surveillance, guide therapeutic selection and improve patient counselling on a global scale.

Research from Nature Portfolio

A seminal population‐based investigation mapped the metastatic trajectories of over 49 000 CRC patients, revealing distinct dissemination signatures between colon and rectal primaries. Rectal cancers demonstrated a higher likelihood of thoracic and neural involvement, whereas colon cancers chiefly metastasised to the liver and peritoneum. Mucinous and signet‐ring subtypes exhibited heightened peritoneal spread but reduced hepatic colonisation. Co‐occurrence patterns were identified—lung metastases often accompanied neural deposits, and peritoneal disease frequently coexisted with ovarian or pleural involvement. Survival analyses in patients with solitary metastases showed median survival ranging from five to nineteen months, contingent on T and N stage. These findings furnish a detailed atlas of CRC spread, informing tailored imaging protocols and early intervention strategies.

Metastatic Patterns and Prognosis in Colorectal Cancer publication trend

The graph below shows the total number of articles in metastatic patterns and prognosis in colorectal cancer across all publications each year (not limited to Nature Index journals).

Technical terms

Metastasis: Spread of cancer cells from the primary tumour to distant organs.

Synchronous metastasis: Secondary tumour deposits identified at or within six months of initial CRC diagnosis.

Metachronous metastasis: Metastatic lesions developing more than six months after primary tumour treatment.

Nomogram: A graphical tool that integrates multiple prognostic factors to estimate individual survival probabilities.

Epigenetic modification: Heritable changes in gene expression caused by DNA methylation or histone remodelling without alteration of the DNA sequence.

References

1. Artificial intelligence based personalized predictive survival among colorectal cancer patients. Computer Methods and Programs in Biomedicine (2023).
2. Exploring Potential Epigenetic Biomarkers for Colorectal Cancer Metastasis. International Journal of Molecular Sciences (2024).
3. Development and validation of prediction models for the prognosis of colon cancer with lung metastases: a population-based cohort study. Frontiers in Endocrinology (2023).
4. Patterns of metastasis in colon and rectal cancer. Scientific Reports (2016).
5. Incidence and management of patients with colorectal cancer and synchronous and metachronous colorectal metastases: a population-based study. BJS Open (2020).